Predictive Clinical and Biological Parameters in Gynecological Cancer

Not Applicable

Recruiting

• Conditions: Cervix Cancer; Ovarian Cancer; Endometrium Cancer

• Registration Number: NCT01977274
• Lead Sponsor: Institut Paoli-Calmettes

Brief Summary

Research of predictive clinical and biological factors in breast cancer : genomic, proteomic, mutation

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2013-10-30
• Study First Submitted QC: 2013-10-30
• Study First Posted: 2013-11-06
• Study Start: 2013-12
• Status Verified: 2020-06
• Last Update Submitted: 2020-06-30
• Last Update Posted: 2020-07-02
• Primary Completion: 2023-12
• Study Completion: 2033-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: Female
• Target Recruitment: 300

Inclusion Criteria

• gynecological cancer suspicion
• age > 18
• signed informed consent

Exclusion Criteria

• emergency

Exclusion criteria after histological exam Any diagnosis that is not a gynecological cancer (ovarian, cervix, endometrium).

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
molecular alteration in gynecological cancer	average of 4 weeks after diagnosis	gene expression level

Secondary Outcome Measures

Name	Time	Method
relation between molecular alteration and clinical and histological characteristics	up to 10 years	hazard ratio between molecular alteration and clinico-histological characteristics

Trial Locations

Locations (1)

Institut Paoli Calmettes; 🇫🇷 Marseille, France